GEMAX
Price
$23.63
Change
-$0.35 (-1.46%)
Updated
Jun 13 closing price
Net Assets
2.81B
VEIEX
Price
$30.56
Change
-$0.41 (-1.32%)
Updated
Jun 13 closing price
Net Assets
116.44B
Interact to see
Advertisement

GEMAX vs VEIEX

Header iconGEMAX vs VEIEX Comparison
Open Charts GEMAX vs VEIEXBanner chart's image
Goldman Sachs Emerging Markets Eq A
Price$23.63
Change-$0.35 (-1.46%)
VolumeN/A
Net Assets2.81B
Vanguard Emerging Mkts Stock Idx I
Price$30.56
Change-$0.41 (-1.32%)
VolumeN/A
Net Assets116.44B
GEMAX vs VEIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GEMAX vs. VEIEX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEMAX is a StrongBuy and VEIEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 116B vs. GEMAX (2.81B). VEIEX pays higher dividends than GEMAX: VEIEX (2.81) vs GEMAX (0.82). GEMAX was incepted earlier than VEIEX: GEMAX (28 years) vs VEIEX (31 years). GEMAX (1.49) is less costly to investors than VEIEX (0.29). GEMAX is a more actively managed with annual turnover of: 36.00 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than GEMAX: VEIEX (0) vs GEMAX (1000). VEIEX (14.12) and GEMAX (13.78) have marching annual gain over last year. VEIEX return over 5 years is better than : 36.09 vs. GEMAX (21.62).
GEMAXVEIEXGEMAX / VEIEX
Total Expense Ratio1.340.29462%
Annual Report Gross Expense Ratio1.490.29514%
Fund Existence28 years31 years-
Gain YTD11.43110.565108%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRA250N/A-
Net Assets2.81B116B2%
Annual Yield % from dividends0.822.8129%
Returns for 1 year13.7814.1298%
Returns for 3 years20.0924.8481%
Returns for 5 years21.6236.0960%
Returns for 10 years53.7539.40136%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AOTAX30.24N/A
N/A
Virtus Emerging Markets Opps A
LGOAX38.63N/A
N/A
Patient Opportunity A
VASVX27.49N/A
N/A
Vanguard Selected Value Inv
HBFBX12.16N/A
N/A
Hennessy Balanced Investor
AVALX46.69N/A
N/A
Aegis Value I